Trailblazer Alzheimer’s Disease Study
Austin Regional Clinic physicians constantly work to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.
Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.
About the Trailblazer study
This study is looking to learn more about how well a new medication works compared to usual care alone for people with early symptoms of Alzheimer’s Disease in the real world.
By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many people in the future. ARC is one of the many study centers in the United States participating in this research study.
What to expect
- If you take part in the Trailblazer Study, you will receive usual care alone. Usual care represents the standard of care that you would receive outside of a research setting.
- You will visit the study center to see if the study is suitable for you.
- A caregiver (your study partner) should be available to answer some questions by telephone about every 6 months during this time.
- Participation in the study's usual care group does not prevent your physician from prescribing and you receiving the treatment at a later time if you decide it is right for you.
- A team of doctors and nurses will monitor your health carefully during the study.
Eligibility criteria
You may be able to take part if you:
- Are 60 years of age or older
- Are under care for presumed mild cognitive impairment or mild dementia stage of Alzheimer’s Disease
- Have a reliable study partner who you are in frequent contact with (and who will be available by telephone at designated times)
Location
Request to participate
Please contact our ARC Clinical Research team to request to participate by calling 737-247-7240.